GLP-1 Agonists: Uses, Mechanism, and Side Effects
https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists The provided text from the Cleveland Clinic offers a comprehensive overview of GLP-1 agonists, a class of medications primarily used to manage Type 2 diabetes and obesity. It explains how these injectable drugs mimic a natural hormone to regulate blood sugar, slow digestion, and increase feelings of fullness, leading to potential weight loss. The source lists various approved GLP-1 agonists and their typical administration frequencies, […]
MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b
MindRank has shared the skinny on its oral GLP-1 receptor agonist, publishing data from a Chinese phase 2b obesity trial that suggests efficacy is in the same ballpark as Eli Lilly’s orforglipron.
Can a Supplement Really Fix Your Libido?
Illustration: Lia Kantrowitz We are living in deeply unsexy times. I mean, the internet’s up in arms over a racy Sabrina Carpenter album cover. Still, people want to be feral again, and they’re turning to supplements to get them there. Last month, Kourtney Kardashian’s vitamin company, Lemme — known for its GLP-1 Daily weight-loss gummies […]
GLP-1 Drug Cuts Migraine Days in Half
A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and chronic migraine. Participants reported an average of 11 fewer headache days per month, alongside improved disability scores and quality of life.
Can Ozempic help lower your risk of dementia?
Post Content
Hims & Hers Health (HIMS) Surged on Weight Loss Offering Advertisement Campaign
Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Russell Midcap Index posted negative returns. Significant policy uncertainty, signaled by aggressive tariff announcements, reversed the positive sentiment prevailing in the […]
Studies address muscle loss caused by GLP-1 drugs
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.
BioNxt launches study for semaglutide oral thin film as alternative to injection/tablets
BioNxt Solutions announces the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic®, Rybelsus®, and Wegovy®. The post BioNxt launches study for semaglutide oral thin film as alternative to injection/tablets appeared first on Innovation News […]
A Safer Path to “Ozempic”: Vitable Health Challenges the “Prescription-First” Trend with a GLP-1 Program Built on Primary Care
PHILADELPHIA–(BUSINESS WIRE)–Vitable Health, the leading all-in-one health benefits platform redefining care for the American workforce, announced the launch of its GLP-1-based weight management services and comprehensive preventative lab panels, now available through its fully integrated Direct Primary Care (DPC) services. As the GLP-1 boom continues, many platforms and compounding pharmacies are rushing to capitalize on […]
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here’s What Investors Need to Know
On April 29, Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell the weight-loss drug Wegovy. Hims & Hers stock soared on the news. It wasn’t a marriage made in heaven. Novo Nordisk revealed on Monday that it will no longer work […]